Key Takeaways
- Traditional fat-blocking capsules (orlistat 60mg/120mg) have the lowest monthly cost but average 5โ10% weight loss without reducing hunger.
- Oral GLP-1 tablets and weekly semaglutide/tirzepatide injections cost more monthly while delivering 2x to 4x greater average percentage weight loss.
- True value depends on maintenance-stage cost per percent of body weight lost, clinical safety, and included medical support.
With more licensed weight-management medications available in 2026 than ever before โ spanning weekly GLP-1 injections, once-daily oral GLP-1 tablets, central craving-control tablets, and lipase-inhibiting capsules โ comparing monthly cost alongside clinical effectiveness helps you plan sustainably.
Comparing medication classes by cost tier & clinical outcome
| Medication Class | Active Ingredient | Administration | Typical Weight Loss | Relative Monthly Cost Tier |
|---|---|---|---|---|
| OTC Lipase Inhibitor | Orlistat 60mg (Alli / Orlos) | 3x daily with meals | ~3%โ5% | Lowest (Entry tier) |
| Rx Lipase Inhibitor | Orlistat 120mg (Xenical) | 3x daily with meals | ~5%โ10% | Low |
| Brain Craving Modulator | Naltrexone / Bupropion | 2 tablets twice daily | ~4%โ9% | Moderate |
| Oral GLP-1 Tablet | Semaglutide 25mg / Orforglipron | Once daily tablet | ~11%โ17% | Mid-to-Upper |
| Weekly GLP-1 Injection | Semaglutide (Wegovy) | Once-weekly pen | ~15%โ17% | Mid-to-Upper |
| Dual GIP/GLP-1 Injection | Tirzepatide (Mounjaro) | Once-weekly pen | ~20%โ22.5% | Upper tier |
Why starter prices don’t tell the whole story
GLP-1 pills and injections follow multi-month dose escalation (0.25mg โ 2.4mg for Wegovy; 2.5mg โ 15mg for Mounjaro; 1.5mg โ 25mg for oral Wegovy). When budgeting, always check all-inclusive monthly pricing across higher strengths so there are no surprise price jumps when you reach maintenance. At Amble, transparent flat-rate plans bundle licensed clinician consultations, prescriptions, and expedited delivery โ check your eligibility in 3 minutes.
References
- Eli Lilly. Mounjaro Summary of Product Characteristics. 2026.
- Novo Nordisk. Wegovy Summary of Product Characteristics. 2026.
- Wharton S, et al. Oral Semaglutide 25 mg in Obesity. N Engl J Med. 2025.
Related Clinical Guides

Your personalizedweight care plan
Clinician-prescribed GLP-1 & metabolic care, 100% online.

Leave a Reply